Background: Cochlear implantation (CI) is a transformative intervention for adolescents with severe-to-profound sensorineural hearing loss, offering benefits that extend beyond auditory rehabilitation to encompass psychosocial and functional outcomes. Despite growing global evidence, there is limited data on the impact of CIs on quality of life (QoL) in low- and middle-income settings, particularly from the adolescent’s perspective. Objective: To evaluate the quality of life of adolescents with unilateral cochlear implants and to assess the influence of demographic and contextual factors on perceived QoL outcomes in a Pakistani cohort. Methods: In this cross-sectional study, 110 adolescents aged 10–19 years with at least 12 months of unilateral CI use were recruited from four rehabilitation centers in Lahore, Pakistan. Participants completed the Glasgow Benefit Inventory (GBI) and a structured demographic questionnaire. Descriptive statistics and inferential analyses compared GBI scores across gender, implant side, and educational placement, with significance set at p < 0.05. Results: The mean GBI total score was 38.6 (SD 11.4), with significant improvements observed across general, social support, and physical health domains (all p < 0.001). No statistically significant differences were found in QoL outcomes by gender, side of implantation, or school type. Strong associations were observed between general well-being and social support. Conclusion: Unilateral cochlear implantation yields substantial, multidimensional quality-of-life benefits for adolescents, independent of demographic or educational context. Integration of psychosocial support and inclusive practices is essential for maximizing post-implant outcomes.
ASRA pain medicine narrative review and expert practice recommendations for gastric point-of-care ultrasound to assess aspiration risk in medically complex patients undergoing regional anesthesia and pain procedures: infographic
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies. However, the lack of consensus on standardized severity definitions, outcome criteria, and terminology remains a major obstacle to clinical investigation and therapeutic development in HHT. Additionally, with the ongoing repurposing of antiangiogenic agents and emerging development of novel HHT‐specific therapies, comparative clinical trials are expected in the future. Therefore, to end the problematic heterogeneity hindering these efforts, the Global Research and Medical Advisory Board (GRMAB) of the Cure HHT Foundation, an international group of recognized HHT experts, convened a conference of expert HHT clinician‐investigators from within GRMAB as well as invited external experts in HHT and bleeding disorders generally, patients with HHT, and patient advocates to define standard terminology and definitions for outcomes and severity classification for bleeding and anemia in HHT. These criteria and definitions should be adopted by regulators, investigators, and the pharmaceutical industry in the development and performance of interventional clinical trials and cohort studies to allow improved comparability between clinical trials, facilitate communication between clinicians and investigators, improve therapeutic guideline development, and provide a standardized framework for regulatory agencies. Search Strategy and Selection Criteria Evidence for this report was systematically identified and evaluated utilizing two search strategies in Ovid MEDLINE, described in full detail in the Appendix, pp.4–13. The searches were conducted on January 7, 2025. The titles and abstracts of each record were reviewed, and the inclusion criteria were applied to all search results to identify full text articles to be retrieved for further review. All retrieved full texts were then reviewed to reach a final determination if a study met the inclusion criteria. Included references were then compiled into evidence tables, which were then utilized by the International Consensus Report Working Group throughout the development of report recommendations.
Clinical Validation of a Computed Tomography Image-Based Machine Learning Model for Segmentation and Quantification of Shoulder Muscles
Introduction: We developed a computed tomography (CT)-based tool designed for automated segmentation of deltoid muscles, enabling quantification of radiomic features and muscle fatty infiltration. Prior to use in a clinical setting, this machine learning (ML)-based segmentation algorithm requires rigorous validation. The aim of this study is to conduct shoulder expert validation of a novel deltoid ML auto-segmentation and quantification tool. Materials and Methods: A SwinUnetR-based ML model trained on labeled CT scans is validated by three expert shoulder surgeons for 32 unique patients. The validation evaluates the quality of the auto-segmented deltoid images. Specifically, each of the three surgeons reviewed the auto-segmented masks relative to CT images, rated masks for clinical acceptance, and performed a correction on the ML-generated deltoid mask if the ML mask did not completely contain the full deltoid muscle, or if the ML mask included any tissue other than the deltoid. Non-inferiority of the ML model was assessed by comparing ML-generated to surgeon-corrected deltoid masks versus the inter-surgeon variation in metrics, such as volume and fatty infiltration. Results: The results of our expert shoulder surgeon validation demonstrates that 97% of ML-generated deltoid masks were clinically acceptable. Only two of the ML-generated deltoid masks required major corrections and only one was deemed clinically unacceptable. These corrections had little impact on the deltoid measurements, as the median error in the volume and fatty infiltration measurements was <1% between the ML-generated deltoid masks and the surgeon-corrected deltoid masks. The non-inferiority analysis demonstrates no significant difference between the ML-generated to surgeon-corrected masks relative to inter-surgeon variations. Conclusions: Shoulder expert validation of this CT image analysis tool demonstrates clinically acceptable performance for deltoid auto-segmentation, with no significant differences observed between deltoid image-based measurements derived from the ML generated masks and those corrected by surgeons. These findings suggest that this CT image analysis tool has potential to reliably quantify deltoid muscle size, shape, and quality. Incorporating these CT image-based measurements into the pre-operative planning process may facilitate more personalized treatment decision making, and help orthopedic surgeons make more evidence-based clinical decisions.
Preserving noise texture through training data curation for deep learning denoising of high‐resolution cardiac EID‐CT
Abstract Background To utilize high spatial resolution reconstructions for cardiac imaging at energy‐integrating detector CT (EID)‐CT with comparable noise to similar reconstructions at photon‐counting detector (PCD)‐CT, methods to control EID‐CT image noise are needed. Supervised convolutional neural networks (CNN) have shown promise for denoising, but a challenge remains to efficiently create high‐quality and unbiased estimates of noise without access to dedicated software or proprietary information, such that natural noise texture is retained in CNN‐denoised CT images. Purpose This study aims to develop and test image‐based noise estimation methods that can be used to train a CNN model, and to evaluate denoising performance and noise texture preservation for EID‐CT coronary CT angiography (cCTA) images reconstructed with high‐resolution kernels. Methods U‐net CNN models were trained for denoising. To supervise training, noise‐only images were estimated directly from high‐resolution kernel (Bv59) reconstructed EID‐CT (HR EID‐CT) patient images using two different methods: subtraction of low‐ and high‐strength iterative reconstruction (IR); subtraction of adjacent image slices with the same IR strength. The noise estimates from these methods contain differing noise texture and anatomical information. Networks were trained and validated separately for three data sets: the training data from each of the two noise‐estimation methods, and a 50%–50% partition of training data between the two methods. The trained models were applied to two sets of testing data: CT images of a uniform water phantom to measure noise power spectra (NPS), and an independent cohort of seven patient cCTA HR EID‐CT exams. The denoised patient images were compared to standard resolution EID‐CT reconstructions (Bv40). As a low‐noise reference, patient images acquired on the same day with a PCD‐CT and reconstructed using a similar kernel as HR EID‐CT were used for comparison. Results Models trained with each noise‐image estimation method denoised the HR EID‐CT images by 74%–79% to achieve a comparable noise magnitude to the HR PCD‐CT images. The peak, average, and 10% peak frequencies of the NPS of the input images (6.08, 6.24, and 12.0 cm −1 ) were better approximated by the model trained on adjacent slice subtraction (6.56, 5.87, and 11.5 cm −1 ) than by the model trained on subtraction of low‐ and high‐IR images (4.64, 5.44, and 11.3 cm −1 ). In cCTA images, the IR subtraction model images retained anatomic structures from input images but resulted in undesirable salt‐and‐pepper noise texture and CT number bias. The model trained on adjacent slice subtraction images had more natural texture and no significant bias, but the model sometimes removed small anatomic structures. The model trained on the mixed training dataset preserved both noise texture and anatomy from the model inputs and enabled visualization of small structures seen in PCD‐CT images that were previously unresolved by EID‐CT. Conclusions The noise texture and anatomical accuracy in CT images denoised with an image‐based supervised CNN are greatly influenced by the characteristics and partitioning of training data. With higher‐resolution reconstructions and noise texture‐preserving deep learning denoising, the quality of cCTA images from EID‐CT can be enhanced to enable resolvability of subtle anatomy similar to PCD‐CT.
In-Bore MRI-Guided Ureteral Stent Placement During Prostate Cancer Cryoablation—A Case Series
Introduction: Ureteral stents are widely used in the specialty of urology to preserve renal function and provide ureteral patency in cases of urolithiasis, strictures, malignancy, and trauma. This paper presents a novel application of prophylactic ureteral stents deployed under MRI-guidance for ureteral protection in the setting of in-bore salvage cryoablation therapy for recurrent and metastatic prostate cancer. This is the first known case series of ureteral stent placement using near real-time MRI. Materials and Methods: A retrospective chart review was performed for all patients who underwent MRI-guided ureteral stent placement prior to in-bore cryoablation therapy from 2021 to 2022. Each case was managed by an interdisciplinary team of urologists and interventional radiologists. Preoperative and postoperative data were collected for descriptive analysis. Physics safety testing was conducted on the cystoscope and viewing apparatus prior to its implementation for stent deployment. Results: A total of seven males, mean age 73.4 years (range 65–81), underwent successful prophylactic, cystoscopic MRI-guided ureteral stent placement prior to cryoablation therapy of their prostate cancer. No intraoperative complications occurred. A Grade 2 postoperative complication of pyelonephritis and gross hematuria following stent removal occurred in one case. The majority of patients were discharged the same day as their procedure. Conclusions: This case series demonstrates the feasibility of in-bore cystoscopic aided MRI guidance for ureteral stent placement. Ureteral stents can be used to increase the safety margin of complex cryoablation treatments close to the ureter. Furthermore, by following the meticulous MRI safety protocols established by MRI facility safety design guidelines, MRI conditional tools can aid therapy in the burgeoning interventional MRI space.
Medical physicist should be a planner in the treatment planning process
Introduction: Amyloidosis complicated by heart failure (HF) poses significant mortality. We sought to identify trends in comorbid amyloidosis and HF mortality in the recent 22- year period. Methods: Mortality due to amyloid and HF as contributors of death were queried from death certificates using the CDC database from 1999 to 2020. Mortality rates and their 95% confidence intervals were adjusted for age (AAMR) through the Direct method and compared by demographic subpopulations. The Monte-Carlo permutation test was used to estimate the annual percentage change (APC). Log-linear regression models were utilized to assess temporal variation in mortality. Results: Age-adjusted mortality rates (AAMR) increased from 0.09 [0.08-0.10] in 1999 to 0.27 [0.25-0.29] in 2020. Mortality increased from 1999 to 2013 (APC +1.4, p=0.048) with an accelerating inflection point in 2013 to 2020 (APC +13.3, p<0.001). AAMR was higher among male populations (AAMR 0.20 [0.20-0.21]) compared to female populations (AAMR 0.07 [0.07- 0.07]). A significant inflection point in uprising mortality rates was observed for both male and female populations in 2013 (p<0.001). Mortality was highest among Black populations (AAMR 0.33), followed by White (AAMR 0.10), Asian/Pacific Islander (AAMR 0.06), and American Indian/Alaska Native populations (AAMR 0.04). Among Black populations, mortality remained consistent from 1999 to 2012 (APC +1.1, p=0.184), followed by an increase from 2012 to 2020 (APC +14.0, p<0.001). Among White populations, mortality remained stagnant from 1999 to 2013 (APC +0.7, p=0.302), followed by an increase starting in 2013 to 2020 (APC +13.5, p<0.001). Discussion: Our findings of a marked rise in HF-related mortality in patients with amyloidosis since 2013 highlighted the profound impact of enhanced diagnostic awareness, novel imaging techniques, and emerging therapeutics. Our analysis also showed mortality disparities between sexes, and geographic locations, races, and ethnicity that warrant targeted public health interventions. Conclusions: Amyloid and HF mortality increased in the recent 22-year period, primarily starting in 2013, emphasizing the urgent need for targeted intervention to address these disparities.